US$ 23.96
glp 1 weight gain after stopping Real-world studies of GLP-1 discontinuation showed that patients often regain at a significantly faster pace than other weight-loss methods. At the same time, however, novel strategies aimed at countering those I went off Wegovy —
Description
2 With the use of GLP-1 receptor agonists becoming increasingly more common, anesthesia professionals need to be aware of these medications and the potential risks they pose to patients receiving anesthesia

Wegovy and Zepbound are FDA-approved for weight loss, unlike similar medications like Ozempic and Mounjaro

For researchers starting a comparative protocol, the practical implication is that tirzepatide offers a broader reference base for benchmarking assay performance and expected magnitudes of effect, while retatrutide provides a more mechanistically novel reference for triple-agonist work

[DOI] [PMC free article] [PubMed] [Google Scholar] 3.American Diabetes Association Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers
2025;26(1) doi: 10.1111/obr.13841

Reduced caloric intake due to appetite suppression may lead to insufficient energy consumption, particularly during the initial treatment phase
